Skip to main content

What's New

Information About Measles and Travel

The New York State Department of Health has released guidance for travel and measles. Click here to read the full release.

The Empire Plan covers the measles, mumps and rubella (MMR) vaccine with no out-of-pocket cost when you use a network medical provider or for adults at a network vaccine pharmacy.

If you are unsure if you are vaccinated, try to find your vaccination records, or consult with your health care provider. Your provider or local health department can help you decide if you need an MMR vaccination.

Prescription Drug Program: Safety Notices

The table below will be updated to include current safety notices or other impactful changes. If you have any questions regarding your prescription drug coverage, please contact The Empire Plan at 1-877-7-NYSHIP (1-877-769-7447) and press or say 4 for the Prescription Drug Program or visit empireplanrxprogram.com. For more information on current recalls/withdrawals please reference Recalls, Market Withdrawals, & Safety Alerts | FDA.

Drug Name

 Effective Date  

 Change

Comment

DEXCOM G6 Receiver

 

January 29, 2025

 

 

 

Medical Device Correction

 

 

 

 

This Urgent Medical Device Correction was issued because users of certain G6 Receivers may experience an issue where alarm/alerts may not function as designed. In such instances, the alarm/alert may be missed or delayed.

This Urgent Medical Device Correction affects:

Part Number

SKUs

Part Description

MT24078


STK-OE-001, STK-OM-001,
STK-OR-001, STR-OM-001,
STR-OR-001

Dexcom G6
Receiver


According to Dexcom, users of the Dexcom G6 Receiver with the impacted software have reported an issue which manifests as follows:

  • Receiver may not alert as designed including missed or delayed alarm/alerts
  • Missed/delayed alarm/alerts may include the following: Low/High Glucose Alerts, Urgent Low Alarm, Urgent Low Soon Alert, Rise/Fall Rate Alerts, Signal Loss Alert, or Sensor Alert

Note: CGM Glucose Values and Glucose Trend Information continue to be displayed on the receiver.

Dexcom has advised that it is working to provide a pathway whereby users can update their receiver to resolve this issue, and that active G6 Receiver users will receive an Urgent: Medical Device Correction Update Notification, via e-mail, regarding the software update availability.

Clonazepam Orally Disintegrating Tablets, USP (C-IV):

  • 0.25mg
  • 0.125mg
  • 2.0mg*
  • 1.0mg*

 

 

 

July 9 & 11, 2024

 

*Expanded on November 19, 2024

 

 

 

Recall

 

 

 

 

 

These recalls were issued due to a limited number of distributed packs that have the incorrect strength “product cartons” as a result of a packaging error at an Endo-contracted packager.  These recalls affect the following Lot numbers:

  Affected Products

NDC #

Lot # / Exp. Date

Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.25 mg

 

Effective 7/9/24

49884-0307-02

550147301 exp. Aug/2026

Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125 mg

 

Effective 7/11/24

49884-0306-02

Clonazepam Orally Disintegrating Tablets, USP (C-IV) 2.0mg

 

Effective 11/19/24

49884-0310-02

550176501 exp. Feb/2027

550174101 exp. Jan/2027

550142801 exp. Aug/2026

550142901 exp. Aug/2026

550143001 exp. Aug/2026

550143101 exp. Aug/2026

550143201 exp. Aug/2026

550143301 exp. Aug/2026

550143401 exp. Aug/2026

550147201 exp. Aug/2026

550147401 exp. Aug/2026

550145201 exp. Aug/2026

550175901 exp. Feb/2027

550176001 exp. Feb/2027

550176201 exp. Feb/2027

550176601 exp. Feb/2027

Clonazepam Orally Disintegrating Tablets, USP (C-IV) 1.0 mg

 

Effective 11/19/24

49884-0309-02

Please call your doctor right away for advice if you might be using an affected medicine. Your doctor knows your medical history and can tell you what to do next. 

Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K

 

 

June 25, 2024

Recall

A consumer-level recall notice was received from Glenmark Pharmaceuticals regarding Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K. This recall was issued because of failed dissolution. This recall affects the following Lot numbers:

  Affected Product

NDC #

Lot #

Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K - 100 count

68462-0357-01

17230619 exp. 02/25

17230624 exp. 02/25

17230879 exp. 03/25

17230890 exp. 03/25

17230918 exp. 03/25

17230984 exp. 03/25

17230996 exp. 03/25

17231002 exp. 03/25

17231081 exp. 03/25

17231102 exp. 04/25

17231135 exp. 04/25

17231329 exp. 04/25

17231369 exp. 05/25

17231513 exp. 05/25

17231516 exp. 06/25

17231713 exp. 06/25

17231909 exp. 06/25

17231903 exp. 06/25

17231943 exp. 08/25

17232166 exp. 09/25

17232179 exp. 09/25

Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K - 500 count

68462-0357-05

17230574 exp. 02/25

17230585 exp. 02/25

17230608 exp. 02/25

17230629 exp. 02/25

17230883 exp. 03/25

17230921 exp. 03/25

17231087 exp. 04/25

17231339 exp. 04/25

17231360 exp. 05/25

17231711 exp. 06/25

17231745 exp. 06/25

17231819 exp. 07/25

17231820 exp. 07/25

17231936 exp. 07/25

17231957 exp. 07/25

17231998 exp. 08/25

17232012 exp. 08/25

17232110 exp. 09/25

17232114 exp. 08/25

17232119 exp. 09/25

17232343 exp. 09/25

Please call your doctor right away for advice if you might be using an affected medicine. Your doctor knows your medical history and can tell you what to do next. 

Potassium Chloride Extended-Release Capsules USP

(750 mg) 10 mEq K

June 26, 2024

Recall

A consumer-level recall notice was received from American Health Packaging regarding Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K. This recall was issued because of failed dissolution. This recall affects the following Lot numbers:

  Affected Product

NDC #

Lot #

Potassium Chloride Extended-Release Capsules USP

(750 mg) 10 mEq K – 100 count

68001-0396-00

17232208 exp. 09/2025

Potassium Chloride Extended-Release Capsules USP

(750 mg) 10 mEq K – 500 count

68001-0396-03

17230796 exp. 02/2025

17230820 exp. 02/2025

17230825 exp. 03/2025

17230833 exp. 03/2025

17230840 exp. 03/2025

17231537 exp. 06/2025

17231540 exp. 06/2025

17231719 exp. 06/2025

17231737 exp. 06/2025

17232111 exp. 09/2025

17232164 exp. 09/2025

Please call your doctor right away for advice if you might be using an affected medicine. Your doctor knows your medical history and can tell you what to do next.

Empire Plan Certificate & Amendments, effective July 1, 2023

Your new Empire Plan Certificate and the accompanying Certificate Amendments are now available. Both the Certificate and Amendments are effective July 1, 2023; the Amendments detail benefits changes since your last Certificate was published.

A printed copy of the Empire Plan Certificate is being mailed to your home address. Keep it with your records and recycle any previous versions you may have. The Certificate Amendments have been incorporated into the new version; they are only available online as a reference for you.